Two weeks after an allogeneic transplant, a patient develops a erythematous maculopapular rash, diarrhea, and elevated liver enzymes. What is the most likely mediator of these symptoms?

Prepare for the NBME Form 16 with our comprehensive quiz. Tackle multiple choice questions with insights and explanations. Enhance your confidence and accuracy for the exam!

Multiple Choice

Two weeks after an allogeneic transplant, a patient develops a erythematous maculopapular rash, diarrhea, and elevated liver enzymes. What is the most likely mediator of these symptoms?

Explanation:
Acute graft-versus-host disease after an allogeneic transplant is driven by donor T lymphocytes attacking host tissues because of differences in MHC antigens. Donor CD4+ and CD8+ T cells become activated by the recipient’s antigen-presenting cells and target organs rich in recipient antigens, especially the skin, gastrointestinal tract, and liver. The resulting inflammation causes the characteristic erythematous maculopapular rash, diarrhea, and elevated liver enzymes. B cells and immune complexes are not the primary mediators in this scenario, and host T cells would more likely mediate rejection of the graft rather than GVHD.

Acute graft-versus-host disease after an allogeneic transplant is driven by donor T lymphocytes attacking host tissues because of differences in MHC antigens. Donor CD4+ and CD8+ T cells become activated by the recipient’s antigen-presenting cells and target organs rich in recipient antigens, especially the skin, gastrointestinal tract, and liver. The resulting inflammation causes the characteristic erythematous maculopapular rash, diarrhea, and elevated liver enzymes. B cells and immune complexes are not the primary mediators in this scenario, and host T cells would more likely mediate rejection of the graft rather than GVHD.

Subscribe

Get the latest from Passetra

You can unsubscribe at any time. Read our privacy policy